METABOLIC CROSS-TALK BETWEEN ER, MITOCHONDRIA, AND NUCLEUS: POSSIBLE IMPACT IN AGING

I.A. Dieterich,Q. Yu,K. Overmyer,J. Coon,L. Li,L. Puglielli

DOI: https://doi.org/10.1093/geroni/igx004.939

2017-01-01

Innovation in Aging

Abstract:Nε-lysine acetylation in the lumen of the endoplasmic reticulum (ER) regulates quality control and proteostasis within the secretory pathway. Mechanistically, it has been established that the import of acetyl-CoA into the ER lumen by the membrane transporter AT-1/SLC33A1 is an essential biochemical component of the ER acetylation machinery. Homozygous mutations in AT-1 are associated with developmental delay and childhood death while heterozygous mutations are associated with a familial form of spastic paraplegia. Finally, gene duplications of AT-1/SLC33A1 have been identified in patients with autistic-like features, intellectual disability and dysmorphic features that are consistent with a diagnosis of segmental progeria. Neuron-specific overexpression of AT-1 in the mouse leads to an autistic-like phenotype while systemic overexpression leads to a progeria-like phenotype that mimics an accelerated form of aging. While dissecting the phenotype of these mice, we discovered the influx of acetyl-CoA into the ER causes epigenetic and mitochondria adaptation. In light of the strong relationship between mitochondria biology and TCA engagement with aging and several age-associated diseases, we decided to use a combination of proteomic and metabolomic approaches to dissect the biochemical and molecular mechanisms that mediate the metabolic and functional adaptation of the mitochondria in the above progeria-like animals. These studies were paralleled by ex vivo genetic approaches to identify novel key regulatory elements. The results show that ACLY, SLC13A5 and SLC25A1 are essential in maintaining acetyl-CoA flux within the cell and a functional cross-talk between the ER and the mitochondria.